Anupam Rasayan India Ltd (NSE: ANURAS) and Neogen Chemicals Limited (Neogen) (NSE: NEOGEN) are both listed in the Custom Synthesis and Specialty CDMO industry. Anupam Rasayan India has a market capitalisation of ₹12,967 Cr and Neogen Chemicals ₹6,295 Cr, as of 9 Nov 2026. Their P/E ratios are 75.5 and 192.3 respectively. Return on equity is 5.76% for Anupam Rasayan India and 3.58% for Neogen Chemicals. Over one year, Anupam Rasayan India's share price is up 11.4% and Neogen Chemicals's is up 81.1%.
| Metric | Anupam Rasayan India | Neogen Chemicals |
|---|---|---|
| NSE Symbol | ANURAS | NEOGEN |
| BSE Code | 543275 | 542665 |
| Share Price | ₹1,205.00 | ₹2,664.00 |
| Market Cap | ₹12,967 Cr | ₹6,295 Cr |
| P/E Ratio | 75.5 | 192.3 |
| Return on Equity | 5.76% | 3.58% |
| Return on Assets | 3.66% | 2.95% |
| Dividend Yield | 0.13% | 0.05% |
| Beta (1Y) | -0.24 | 0.83 |
| 1-Year Price Change | +11.4% | +81.1% |
| 3-Month Price Change | -0.9% | +22.0% |
| 52-Week Range | ₹1,059.10 – ₹1,415.00 | ₹979.80 – ₹2,785.00 |
| Latest Quarter | Q2 FY27 | Q2 FY27 |
| Quarterly Revenue | ₹806 Cr | ₹296 Cr |
| Quarterly Net Profit | ₹65 Cr | ₹8 Cr |
| Net Margin | 8.1% | 2.8% |
| EPS (Basic, Quarter) | ₹4.39 | ₹2.96 |
| Results Basis | consolidated | consolidated |
| Headquarters | Surat, Gujarat | Thane, Maharashtra |
The figures sit side by side and are not ranked. Quarterly figures are in ₹ crore, parsed from each company's exchange filing (XBRL); the two companies' latest quarters can differ.
Anupam Rasayan India Ltd engages in the custom synthesis and manufacturing of specialty chemicals in India, Europe, Japan, Singapore, China, North America, and internationally. It operates through two segments: Life Science related Specialty Chemicals and Other Specialty Chemicals. The company offers life science related specialty chemicals, such as agro intermediates and agro active ingredients for the agrochemicals industry; anti-bacterial and ultraviolet protection intermediates and ingredients for the personal care industry; and intermediates and key starting materials for active pharmaceu…
Neogen Chemicals Limited engages in the manufacture and sale of specialty chemicals in India. It offers organo bromine compounds, such as alkyl bromide compounds, dibromoalkane compounds, bromo chloro alkanes, bromine derivatives of organoacids, bromoacid ester compounds, aromatic bromine derivatives, cyclic bromine derivatives, and speciality bromo fluro derivatives; speciality chloro compounds comprising unsaturated bromine derivatives, bromo hydroxy derivatives, and other compounds; and organo lithium compounds, including n-butyl lithium, lithium hexamethyldisilazide, lithium tetrahydride b…
Anupam Rasayan India has a market capitalisation of ₹12,967 Cr, against ₹6,295 Cr for Neogen Chemicals as of 9 Nov 2026, about 2.1 times the size by market cap.
Anupam Rasayan India has a P/E of 75.5 and Neogen Chemicals a P/E of 192.3 as of 9 Nov 2026.
Anupam Rasayan India has a return on equity of 5.76% and Neogen Chemicals 3.58%.
Anupam Rasayan India's share price is up 11.4% over one year and Neogen Chemicals's is up 81.1%.
Anupam Rasayan India reported revenue of ₹806 Cr and net profit of ₹65 Cr for Q2 FY27. Neogen Chemicals reported revenue of ₹296 Cr and net profit of ₹8 Cr for Q2 FY27. Figures are parsed from each company's exchange filing.
Both are classified under Speciality Chemicals > Specialty Chemicals > Custom Synthesis and Specialty CDMO on FinBizNet.
No. The page lays the two companies' published figures side by side and draws no conclusion from them. It is descriptive market data, not investment advice.
Data as of 9 Nov 2026. Descriptive market data only — not investment advice.